Single Blind Clinical Study of Shodhana Karma and an indigenous Drug Combination on Polycystic Ovarian Disease

Single Blind Clinical Study of Shodhana Karma and an indigenous Drug Combination on Polycystic Ovarian Disease - PCOD

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/12/007523

Enrollment

100

Registered

2016-12-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnostic cases of PCOD

Interventions

Intervention1: Asanadi gana quata,kanchanaraguggulu and shatapushpa churna: Asanadi gana quata and kanchanaraguggulu having the property of kapha meda haratwa, being indicated in granti and prameha, s

Eligibility

Inclusion criteria

Inclusion criteria: PCOD with hypothyroidism PCOD with infertility PCOD with menstrual irregularity Diagnostic cases of PCOD with the help of ultrasonography and hormonal assay

Exclusion criteria

Exclusion criteria: Cases of obesity other than PCOD Ammenorrhoea due to pregnancy, genital tuberculosis and premature ovarian failure PCOD cases with severe systemic illness

Design outcomes

Primary

Measure	Time frame
Regularization of menstrual cycle Conception in eligible infertile couple Normalization of PCOD findings in ultrasonography and hormonal assay Timepoint: Regularization of menstrual cycle Conception in eligible infertile couple Normalization of PCOD findings in ultrasonography and hormonal assay	—

Secondary

Measure	Time frame
Regularization of menstrual cycle Conception in eligible infertile couple Normalization of PCOD findings in ultrasonography and hormonal assay Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDr Mamatha

SDM College of Ayurveda and Hospital Kuthpady

mamath2@gmail.com08202520332

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026